DEXCOM INC — Director's Dealing 2023

May 22, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2023-05-18

Reporting Person: Heller Bridgette P (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-05-18	Common Stock	A	2911	$0.001	Acquired	24331	Direct

Footnotes

F1: The RSU Award was granted on May 18, 2023 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2024 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.

F2: Included in this number are 2,911 unvested restricted stock units which were granted on May 18, 2023 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2024 Annual Meeting.